CareRx Corporation (CHHHF)
| Market Cap | 137.02M -15.0% |
| Revenue (ttm) | 266.87M +3.4% |
| Net Income | 18.01M +27,386.0% |
| EPS | 0.28 +26,603.8% |
| Shares Out | n/a |
| PE Ratio | 8.64 |
| Forward PE | 35.78 |
| Dividend | 0.06 (2.45%) |
| Ex-Dividend Date | Dec 14, 2026 |
| Volume | 100 |
| Open | 2.320 |
| Previous Close | 2.440 |
| Day's Range | 2.320 - 2.440 |
| 52-Week Range | 2.310 - 2.890 |
| Beta | 0.56 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About CareRx
CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada. [Read more]
News
CareRx price target lowered to C$4.25 from C$4.50 at Stifel
Stifel analyst Justin Keywood lowered the firm’s price target on CareRx (CHHHF) to C$4.25 from C$4.50 and keeps a Buy rating on the shares.
CareRx price target lowered to C$4 from C$4.50 at Canaccord
Canaccord lowered the firm’s price target on CareRx (CHHHF) to C$4 from C$4.50 and keeps a Buy rating on the shares.
CareRx Earnings Call Transcript: Q3 2026
Q3 revenue rose 2.2% YoY to CAD 95.3M, with adjusted EBITDA of CAD 8.1M and 93,225 average beds serviced. The 3,000-bed onboarding supports Q4, while fuel costs and labor timing remain margin pressures.
CareRx Report: Q3 2026
CareRx published a report on November 5, 2026 containing material business information for investors and shareholders.
CareRx MD&A: Q3 2026
CareRx filed a regulatory document on November 5, 2026 disclosing important business information.
CareRx Earnings release: Q3 2026
CareRx released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
CareRx Slides: Q3 2026
CareRx has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 5, 2026.
CareRx Announces Q4 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - November 4, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregat...
CareRx Reports Results for the Third Quarter of 2026
Toronto, Ontario--(Newsfile Corp. - November 4, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregat...
Irish private healthcare provider Centric Health to be sold to US group
CareRx Receives Regulatory Approval for Renewal of its Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congreg...
CareRx Slides: Investor presentation
CareRx has posted slides in relation to its latest quarterly earnings report, which was published on September 1, 2026.
CareRx Announces New Credit Agreement with National Bank of Canada
Toronto, Ontario--(Newsfile Corp. - August 27, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate...
CareRx Earnings Call Transcript: Q2 2026
Q2 2026 saw stable revenue and EBITDA, with net income impacted by Ontario ward bed funding changes. A major contract win will add 3,000 retirement beds in Q3, supporting growth targets. Dividend was raised 10%, and margin benefits from generics are expected in 2027.
CareRx Earnings release: Q2 2026
CareRx released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
CareRx MD&A: Q2 2026
CareRx filed a regulatory document on July 30, 2026 disclosing important business information.
CareRx Report: Q2 2026
CareRx published a report on July 30, 2026 containing material business information for investors and shareholders.
CareRx Slides: Q2 2026
CareRx has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
CareRx Corporation to Host Second Quarter 2026 Financial Results Conference Call on Thursday, July 30, 2026 at 8:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its second quarter 2026 financ...
CareRx Reports Voting Results from Annual General Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - CareRx Corporation (TSX: CRRX) (the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communiti...
CareRx Earnings Call Transcript: Q1 2026
Q1 2026 saw strong revenue and margin growth, driven by new beds and efficiency gains. Ontario's funding stability supports long-term outlook, though removal of ward bed funding may reduce fees by up to CAD 2 million. Generic semaglutide launch expected to benefit margins in 2027.
CareRx Earnings release: Q1 2026
CareRx released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
CareRx Slides: Q1 2026
CareRx has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
CareRx Report: Q1 2026
CareRx published a report on May 7, 2026 containing material business information for investors and shareholders.
CareRx MD&A: Q1 2026
CareRx filed a regulatory document on May 7, 2026 disclosing important business information.